The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.
Despite granting the FDA enhanced authority to mandate postmarketing studies, revise safety labels, and enforce active surveillance, the FDAAA was not associated with statistically significant ...
MedPage Today on MSN
Novel ITP Drug Helps Patients Ditch Daily Meds
ORLANDO -- Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily ...
ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...
Ianalumab (9 mg/kg) plus eltrombopag extended ITP disease control by 45% with patients maintaining disease control 2.8 times longer than with placebo plus eltrombopag1,262% of patients treated with ...
Zacks Investment Research on MSN
GPCR stock soars 102% on strong phase II obesity data for Aleniglipron
Shares of Structure Therapeutics GPCR skyrocketed 102.5% after the company reported positive top-line data from the ACCESS ...
Nigeria's government states its anti-corruption fight can be won by empowering youth with skills and opportunities to resist ...
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...
A new finding from researchers at Georgetown University Medical Center shows that the learning process of associating cues ...
7hon MSN
Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...
Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...
Scientists discovered that altering levels of the KCC2 protein can dramatically change how the brain forms reward associations. Reduced KCC2 boosts dopamine activity, making new habits—good or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results